Abstract: Compositions having broad effectiveness against bacterial and fungi, which comprise (a) an iodopropynylbutyl compound and (b) one or more formaldehyde donor compounds, the formaldehyde donor compounds being N-formals, O-formals and/or a combination thereof. The compositions are also stable and effective in the form of liquid concentrates. The present invention also relates to the use of such compositions in industrial products and to industrial products which comprise these compositions.
Type:
Grant
Filed:
May 22, 2001
Date of Patent:
October 22, 2002
Assignee:
Air Liquide Sante (International)
Inventors:
Wolfgang Beilfuss, Wolfgang Siegert, Klaus Weber
Abstract: The present invention relates to stable microbicidal compositions which are characterized in that they comprise derivatives of methylenebisoxazolidine and 1H-benzimidazol-2-ylcarbamic acid. The compositions according to the invention can be employed in industrial products. The derivatives of methylenebisoxazolidine are used, in particular, for increasing the solubility of derivatives of 1H-benzimidazol-2-ylcarbamic acid in liquid preparations.
Abstract: Process for the preparation of bis(4-amino-1-pyridinium)alkanes by reacting difunctionalized alkanes with 4-aminopyridines in water or a mixture of water and organic solvent.
Type:
Grant
Filed:
February 9, 2001
Date of Patent:
April 30, 2002
Assignee:
Air Liquide Sante (International)
Inventors:
Wolfgang Beilfuss, Ralf Gradtke, Michael Streek
Abstract: The invention relates to the use of an N,N′-substituted glycine or of an N,N′-substituted derivative of glycine (a) of the general formula I
in which R1 is hydrogen or a straight-chain or branched, saturated or unsaturated alkyl, alkaryl or aralkyl radical having 1 to 30 C atoms, which can optionally contain heteroatoms such as O, S and N, R2 is a straight-chain or branched, saturated or unsaturated alkyl, alkaryl or aralkyl radical having 1 to 30 C atoms containing at least one primary, secondary or tertiary amino group and X is OH, OR3, NH2, NHR4, NR4R5 or O−M+, where R3, R4 and R5 are straight-chain or branched, saturated or unsaturated alkyl, alkaryl or aralkyl radicals which can be identical to or different from one another, and M is a metal cation, as active compound in a tuberculocidal disinfectant.
Type:
Grant
Filed:
January 15, 1999
Date of Patent:
April 23, 2002
Assignee:
L'Air Liquide SANTE (International)
Inventors:
Sabine Behrends, Andreas Dettmann, Michael Mohr
Abstract: The invention concerns the use of at least one gas in combination with at least one active product for manufacturing an inhalable medicament or part of an inhalable medicament intended for the treatment or prevention of pain in humans or animals. The gas is chosen from among helium, oxygen, nitrogen, xenon, hydrogen, carbon monoxide (CO), carbon dioxide (CO2), argon, krypton, nitrogen monoxide (NO), nitrogen protoxide (N2O), carbonated hydrocarbons, fluorocarbons and mixtures of several of these gases. The active product is chosen from among paracetamol, acetylsalicylic acid, arylcarboxylic acid, corticosteroids, mineralosteroids, non-steroidal anti-inflammatory drugs and their derivatives, codeine and its derivatives, morphine and morphine mimetics.
Type:
Application
Filed:
August 3, 2001
Publication date:
March 21, 2002
Applicant:
AIR LIQUIDE SANTE (INTERNATIONAL)
Inventors:
Laurent Lecourt, Franck Lescure, Marc Lemaire
Abstract: Compositions having broad effectiveness against bacteria and fungi, which comprise (a) an iodopropynylbutyl compound and (b) one or more formaldehyde donor compounds, the formaldehyde donor compounds being N-formals, O-formals and/or a combination thereof. The compositions are also stable and effective in the form of liquid concentrates. The present invention also relates to the use of such compositions in industrial products and to industrial products which comprise these compositions.
Type:
Grant
Filed:
November 23, 1999
Date of Patent:
March 12, 2002
Assignee:
Air Liquide Sante (International)
Inventors:
Wolfgang Beilfuss, Wolfgang Siegert, Klaus Weber
Abstract: The present invention relates to stable microbicidal compositions which are characterized in that they comprise derivatives of methylenebisoxazolidine and 1H-benzimidazol-2-ylcarbamic acid. The compositions according to the invention can be employed in industrial products. The derivatives of methylenebisoxazolidine are used, in particular, for increasing the solubility of derivatives of 1H-benzimidazol-2-ylcarbamic acid in liquid preparations.
Abstract: A portable apparatus for domiciliary and ambulatory oxygen therapy intended for people suffering from respiratory insufficiencies and treated by administering gaseous oxygen so as to correct the gas contents in their blood, in particular the carbon dioxide and oxygen contents. The system includes an air compression device; a concentrator device allowing gaseous oxygen having a purity of 50 to 99% to be produced; an oxygen liquefaction device; an accumulation and storage device for the oxygen liquefied by the liquefaction device; a liquefied-oxygen warming and vaporizing device; and a gas transport section for conveying the oxygen warmed and vaporized by the warming/vaporizing device to a gas delivery interface connected to the upper airways of a user.
Abstract: A disinfectant composition and process for making the same. The composition comprises octenidine dihydrochloride, at least one C1 to C8-alkyl alcohol, at least one surfactant chosen among non-ionic or cationic surfactants, water and optionally at least one &agr;-hydroxycarboxylic acid.
Type:
Application
Filed:
June 12, 2001
Publication date:
November 1, 2001
Applicant:
Air Liquide Sante (International)
Inventors:
Sabine Behrends, Peter Goroncy-Bermes, Michael Mohr, Burghard Puchstein
Abstract: Compositions having broad effectiveness against bacterial and fungi, which comprise (a) an iodopropynylbutyl compound and (b) one or more formaldehyde donor compounds, the formaldehyde donor compounds being N-formals, O-formals and/or a combination thereof. The compositions are also stable and effective in the form of liquid concentrates. The present invention also relates to the use of such compositions in industrial products and to industrial products which comprise these compositions.
Type:
Application
Filed:
May 22, 2001
Publication date:
October 25, 2001
Applicant:
Air Liquide Sante (International)
Inventors:
Wolfgang Beilfuss, Wolfgang Siegert, Klaus Weber
Abstract: A process and installation for the regulation of the vacuum level prevailing in a network of vacuum conduits in a hospital building comprises one or several vacuum pumps connected pneumatically to the vacuum conduits (CV); elements (C2) for determining the pressure to determine the underpressure prevailing in the vacuum conduits (CV); a pilot device (MP) controlling at least one vacuum pump, at least one line for connection to the atmosphere (L1, L2) having a first end connected pneumatically to the vacuum conduits and having a second free end; and control elements (EV1, EV2) for the flow of fluid arranged in the line for connection to the atmosphere (L1, L2) to permit controlling the passage of air in the line connecting to the atmosphere.
Type:
Grant
Filed:
January 18, 2000
Date of Patent:
October 2, 2001
Assignee:
Air Liquide Sante (International)
Inventors:
Emmanuel Guillet-Belaud, Robert Montausier, Didier Beauvois
Abstract: Process for the preparation of bis(4-amino-1-pyridinium)alkanes by reacting difunctionalized alkanes with 4-aminopyridines in water or a mixture of water and organic solvent.
Type:
Application
Filed:
February 9, 2001
Publication date:
August 23, 2001
Applicant:
AIR LIQUIDE SANTE (INTERNATIONAL)
Inventors:
Wolfgang Beilfuss, Ralf Gradtke, Michael Streek
Abstract: A process and device for treatment of water circulating in a conduit, which water carries microorganisms that must be eliminated and ions susceptible of leading to the formation of deposits on the internal wall of the conduit. To this end, there is injected in the water to be treated effective quantities of ozone and carbon dioxide. Particularly useful to treat the water conduits of a hospital building.
Abstract: A process and compositions for disinfecting the skin, hands and mucous membrane. The compositions contain an optical brightener and exhibit intense fluorescence in the visible wavelength range on exposure to UV light and thus permit simple monitoring of the treated skin or mucous membrane surfaces for ensuring complete disinfection, but without exhibiting the disadvantages associated with the use of conventional dyes, such as discoloration of the skin and articles.
Abstract: A process and device for treatment of water circulating in a conduit, which water carries microorganisms that must be eliminated and ions susceptible of leading to the formation of deposits on the internal wall of the conduit. To this end, there is injected in the water to be treated effective quantities of ozone and carbon dioxide. Particularly useful to treat the water conduits of a hospital building.